| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016605 |
| Receipt No. | R000019270 |
| Official scientific title of the study | Effects of lanthanum carbonate on arterial stiffness in patients with CKD 3-5 not on dialysis |
| Date of disclosure of the study information | 2015/03/01 |
| Last modified on | 2018/12/31 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effects of lanthanum carbonate on arterial stiffness in patients with CKD 3-5 not on dialysis | |
| Title of the study (Brief title) | Effects of lanthanum carbonate on arterial stiffness in patients with CKD 3-5 not on dialysis | |
| Region |
|
|
| Condition | ||
| Condition | non-dialysis chronic kidney disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the effect of lanthanum carbonate and/or existing treatment on markers of arterial stiffness, left ventricular mass and oxidative stress in chronic kidney disease (CKD) stage 3-5 not on dialysis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change from baseline and compare between 2 groups, as follows : Pulse wave velocity, Left ventricular mass and oxidative stress makers (nitrotyrosine, AGE, RAGE, Urinary 8-OHdG, Skin accumulation of AGE) |
| Key secondary outcomes | Change from baseline and compare between 2 groups, as follows: Phosphate, Calcium, FGF-23, soluble alfa-Klotho , iPTH, eGFR, Cr,1/Cr, OC, CRP |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is considered as a block. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Lanthanum carbonate | |
| Interventions/Control_2 | Existing treatment for chronic kidney disease | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with CKD stage G3-G5 (eGFR< 60mL/min/1.73m2 ) not on dialysis
2) CKD-MBD patients without receiving phosphate binder treatment (%TRP<85% ) 3) Written informed consent |
|||
| Key exclusion criteria | 1) <20years old
2) Treatment with lanthanum carbonate within the past two months 3) Contraindications to lanthanum carbonate 4) Inflammatory disease 5) Malignancy of any type 6) History of renal transplantation 7) Pregnant or breast-feeding women 8) Ineligible patients for this study according to the investigator's judgment |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Kei Fukami |
| Organization | Kurume University School of Medicine |
| Division name | Division of Nephrology, Department of Medicine |
| Address | 67 Asahi-machi, Kurume city, Fukuoka |
| TEL | +81-942-35-3311 |
| fukami@med.kurume-u.ac.jp | |
| Public contact | |
| Name of contact person | Kei Fukami |
| Organization | Kurume University School of Medicine |
| Division name | Division of Nephrology, Department of Medicine |
| Address | 67 Asahi-machi, Kurume city, Fukuoka |
| TEL | +81-942-35-3311 |
| Homepage URL | |
| fukami@med.kurume-u.ac.jp | |
| Sponsor | |
| Institute | Kurume University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Bayer Yakuhin, Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 久留米大学病院(福岡県)/Kurume University School of Medicine (Fukuoka) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019270 |